Literature DB >> 35850662

Capillary refill time for the management of acute circulatory failure: a survey among pediatric and adult intensivists.

Matthias Jacquet-Lagrèze1,2,3,4, Cléo Wiart5, Rémi Schweizer5,6, Léa Didier5,6, Martin Ruste5,6, Maxime Coutrot7,8, Matthieu Legrand9, Florent Baudin6,10, Etienne Javouhey6,10, François Dépret7,8, Jean-Luc Fellahi5,6,11.   

Abstract

INTRODUCTION: Recent studies have shown the prognostic value of capillary refill time (CRT) and suggested that resuscitation management guided by CRT may reduce morbidity and mortality in patients with septic shock. However, little is known about the current use of CRT in routine clinical practice. This study aimed to assess the modalities of CRT use among French adult and pediatric intensivists.
METHODS: A cross-sectional survey exploring CRT practices in acute circulatory failure was performed. The targeted population was French adult and pediatric intensivists (SFAR and GFRUP networks). An individual invitation letter including a survey of 32 questions was emailed twice. Descriptive and analytical statistics were performed.
RESULTS: Among the 6071 physicians who received the letter, 418 (7%) completed the survey. Among all respondents, 82% reported using CRT in routine clinical practice, mainly to diagnose acute circulatory failure, but 45% did not think CRT had any prognostic value. Perfusion goal-directed therapy based on CRT was viewed as likely to improve patient outcome by 37% of respondents. The measurement of CRT was not standardized as the use of a chronometer was rare (3%) and the average of multiple measurements rarely performed (46%). Compared to adult intensivists, pediatric intensivists used CRT more frequently (99% versus 76%) and were more confident in its diagnostic value and its ability to guide treatment.
CONCLUSION: CRT measurement is widely used by intensivists in patients with acute circulatory failure but most often in a non-standardized way. This may lead to a misunderstanding of CRT reliability and clinical usefulness.
© 2022. The Author(s).

Entities:  

Keywords:  Acute circulatory failure; Capillary refill time; Peripheral perfusion; Shock; Survey

Mesh:

Year:  2022        PMID: 35850662      PMCID: PMC9290243          DOI: 10.1186/s12873-022-00681-x

Source DB:  PubMed          Journal:  BMC Emerg Med        ISSN: 1471-227X


Introduction

Recent cohort studies have emphasized the prognostic value of capillary refill time (CRT) [1-3] and a recent clinical trial suggested that resuscitation management guided by CRT measurement may reduce morbidity and mortality in patients with septic shock [4, 5]. Subsequently, the clinical benefit has been endorsed by the recent guidelines of the surviving sepsis campaign [6, 7]. When used for research purposes, CRT requires a standardized approach encompassing the number of averaged CRT values, the level of pressure applied to the skin, the duration of skin compression, the localization of the test, and the use of a chronometer. Although CRT has proven to be useful and potentially lifesaving, little is known about its use in real-life conditions and how it is performed in routine clinical practice. It is however likely that CRT is both underused and misused and that healthcare providers do not strictly follow the standard at the bedside, creating a wide variability in practices. Such a sub-optimal use of CRT could lead to a misunderstanding of its reliability and clinical usefulness. To date, no study has focused on assessing the modalities of CRT use in routine clinical practice among adult and pediatric intensivists. This cross-sectional survey aimed at describing and analyzing the practices in terms of CRT use among French adult and pediatric intensivists, in the setting of acute circulatory failure.

Methods

The networks from the Société Française d’Anesthésie et de Réanimation (SFAR) and the Groupe Francophone de Réanimation et Urgences Pédiatriques (GFRUP) were solicited in September and October 2021 and asked to email, twice, an invitation letter for survey participation at each physician member of the networks, who are mainly adult/pediatric anesthesiologists and/or intensivists. The members of these learned societies are mainly from France, but also from Belgium, Algeria, Tunisia, Morocco, Luxembourg, and Canada. Responses of different physicians from the same institution were allowed. The invitation letter explained the purposes and benefits of the survey and gave a link to the dedicated web page (Survey Monkey, Palo Alto, CA, USA). The survey included a total of 32 questions, XX of which were multiple choice questions, and is available in Additional files 1 and 2. The entire survey took approximately 10 min to complete. Two authors (CW and MJL) designed the questions and distributed them for comments and modifications within the scientific committee of the study (JLF, ML, FD, MC, RS, FB, EJ). Thereafter, the survey was sent to a test group of 15 physicians to test both its feasibility and overall quality. The demographic characteristics of the physicians were collected. The reasons why the physicians perform CRT and how they consider and interpret it were explored. The approach used to perform CRT in routine clinical practice was also assessed and the potential leads to improve clinical practice when using CRT were examined.

Statistical analysis

Categorical variables were expressed as frequencies and percentages, and continuous variables as mean ± standard deviation. Chi-squared tests were used to perform between-group comparisons. All tests were two-sided, and a p-value < 0.05 was considered statistically significant. The descriptive and analytical statistical analyses were computed using the Free Software Foundation’s CRAN R, R version 4.0.4.

Results

Test feasibility and quality

The 15 physicians who initially answered the survey test reported no issues in terms of feasibility, and the overall quality was rated as good. The comments were used to refine the final version of the survey.

Characteristics of the respondents

Among the 6071 physicians who received and opened the email in September and October, 549 (9%) clicked on the survey link. The survey was then completed by 418 (7%) practitioners. The mean ± SD age of the respondents was 39 ± 10 years and the mean ± SD time of clinical experience and practice was 11 ± 9 years. Overall, 60% of respondents worked in an adult intensive care unit (ICU), 30% in a pediatric ICU, and 7% worked in an adult or pediatric emergency department. The respondents practiced mainly in tertiary teaching hospitals (63%), public hospitals (27%), and private hospitals (9%). Among all respondents, 55% worked in units with 11 to 20 beds, and 28% worked in units with more than 20 beds. Overall, 48% of respondents managed 1 to 5 patients with acute circulatory failure per week (Table 1).
Table 1

Characteristics of the survey respondents

OverallAdult practicePediatric practicep-value
n418308110
Age, years, mean (SD)39 (10)39 (11)40 (8)0.421
Clinical practice, years, mean (SD)11 (9)11 (10)12 (8)0.577
Health care facility location, n (%)
 Africa13 (3.1)13 (4.2)0 (0.0)0.029
 America3 (0.7)1 (0.3)2 (1.8)
 Other European country6 (1.4)5 (1.6)1 (0.9)
 France366 (87.6)272 (88.3)94 (85.5)
 Overseas France19 (4.5)10 (3.2)9 (8.2)
 No answer11 (2.6)7 (2.3)4 (3.6)
Clinical activity, n (%)
 Adult ICU251 (60.0)251 (81.5)0 (0.0)< 0.001
 Pediatric ICU127 (30.4)30 (9.7)97 (88.2)
 Adult high depency unit110 (26.3)108 (35.1)2 (1.8)
 Pediatric high depency unit73 (17.5)12 (3.9)61 (55.5)
 Adult emergency department14 (3.3)14 (4.5)0 (0.0)
 Pediatric emergency department14 (3.3)2 (0.6)12 (10.9)
 Other57 (13.6)40 (13.0)17 (14.7)
Medical specialty, n (%)
 Intensivist and anesthesiologist286 (68.4)283 (91.9)3 (2.7)< 0.001
 Intensivist39 (9.3)27 (8.8)12 (10.9)
 Cardiologist or pneumologist4 (0.9)3 (0.9)1 (0.9)
 Pediatrician (%)110 (26.3)0 (0.0)110 (100.0)
 Other (%)29 (6.9)20 (6.5)9 (8.2)
Health care facility, n (%)
 Tertiary teaching hospital265 (63.4)178 (57.8)87 (79.1)< 0.001
 Private hospital39 (9.3)39 (12.7)0 (0.0)
 Public hospital114 (27.3)91 (29.5)23 (20.9)
Number of beds in health care facility, n (%)
 0 to1070 (16.7)50 (16.2)20 (18.2)0.833
 11 to 20230 (55.0)172 (55.8)58 (52.7)
 >  20118 (28.2)86 (27.9)32 (29.1)
Weekly number of patients with acute circulatory failure in respondent’s care, n (%)
 <  1 patient a week81 (19.4)48 (15.6)33 (30.0)< 0.001
 1 to 5 patients a week199 (47.6)132 (42.9)67 (60.9)
 5 to 10 patients a week98 (23.4)88 (28.6)10 (9.1)
 >  10 patients a week40 (9.6)40 (13.0)0 (0.0)
Characteristics of the survey respondents

How physicians consider and interpret CRT

Among all respondents, 82% reported using CRT in routine clinical practice, while others did not consider CRT to be reliable (8%) or reproducible (9%) enough for daily use. Furthermore, 308(74%) respondents declared that 3 seconds was the threshold to define abnormal CRT, 29% were convinced CRT could be used to diagnose acute circulatory failure, and 35% thought it could probably have a diagnostic value (Table 2 and Fig. 1). Conversely, 8% considered that CRT had no diagnostic value and 4% felt it was useless in routine clinical practice. Regarding the prognostic value of CRT, 45% thought it had none, while 55% felt CRT probably or certainly reflects tissue perfusion and 47% thought it does not reflect cardiac output. In the setting of acute coronary failure, 37% of respondents considered that a perfusion goal-directed therapy based on CRT measurement could probably or certainly improve patient outcome. In line with these results, 52% of respondents reported never targeting the normalization of CRT during their resuscitation strategy compared to 6% who always do. Finally, 3% declared that a perfusion-targeted protocol based on CRT was in place in their institution to resuscitate patients with acute circulatory failure.
Table 2

How respondents use and interpret capillary refill time

OverallAdult practicePediatric practicep-value
n = 418n = 308n = 110
Would you say that capillary refill time is a reliable measurement in clinical practice, n (%)
 No34 (8.1)31 (10.1)3 (2.7)< 0.001
 Possibly139 (33.3)123 (39.9)16 (14.5)
 Probably146 (34.9)96 (31.2)50 (45.5)
 Certainly99 (23.7)58 (18.8)41 (37.3)
Would you say that capillary refill time is a reproducible measurement in clinical practice, n (%)
 No37 (8.9)32 (10.4)5 (4.5)0.001
 Possibly92 (22.0)79 (25.6)13 (11.8)
 Probably129 (30.9)93 (30.2)36 (32.7)
 Certainly160 (38.3)104 (33.8)56 (50.9)
According to you, what is the pathological threshold of capillary refill time, n (%)
 It depends on the clinical context; we cannot define a threshold39 (9.3)34 (11.0)5 (4.5)0.002
 More than 2 seconds27 (6.5)13 (4.2)14 (12.7)
 More than 3 seconds308 (73.7)223 (72.4)85 (77.3)
 More than 5 seconds43 (10.3)37 (12.0)6 (5.5)
 More than 7 seconds1 (0.2)1 (0.3)0 (0.0)
Do you think that capillary refill time can be used to diagnose acute circulatory failure, n (%)
 No34 (8.1)27 (8.8)7 (6.4)0.012
 Possibly114 (27.3)96 (31.2)18 (16.4)
 Probably148 (35.4)103 (33.4)45 (40.9)
 Certainly122 (29.2)82 (26.6)40 (36.4)
Do you think that capillary refill time has a prognostic value in patients with acute circulatory failure, n (%)
 No190 (45.5)122 (39.6)68 (61.8)0.001
 Possibly122 (29.2)97 (31.5)25 (22.7)
 Probably69 (16.5)58 (18.8)11 (10.0)
 Certainly37 (8.9)31 (10.1)6 (5.5)
Do you think that capillary refill time is a reliable surrogate marker of tissue perfusion, n (%)
 No54 (12.9)45 (14.6)9 (8.2)0.206
 Possibly135 (32.3)102 (33.1)33 (30.0)
 Probably162 (38.8)112 (36.4)50 (45.5)
 Certainly67 (16.0)49 (15.9)18 (16.4)
Do you think that capillary refill time is a surrogate marker of cardiac output, n (%)
 No195 (46.7)154 (50.0)41 (37.3)0.133
 Possibly150 (35.9)105 (34.1)45 (40.9)
 Probably50 (12.0)33 (10.7)17 (15.5)
 Certainly23 (5.5)16 (5.2)7 (6.4)
Do you think that a perfusion goal-directed therapy based on capillary refill time could reduce mortality in patients with acute circulatory failure, n (%)
 No81 (19.4)63 (20.5)18 (16.4)0.027
 Possibly182 (43.5)143 (46.4)39 (35.5)
 Probably116 (27.8)79 (25.6)37 (33.6)
 Certainly39 (9.3)23 (7.5)16 (14.5)
Do you think that capillary refill time is useful in clinical practice, n (%)
 No18 (4.3)16 (5.2)2 (1.8)< 0.001
 Possibly88 (21.1)79 (25.6)9 (8.2)
 Probably130 (31.1)100 (32.5)30 (27.3)
 Certainly182 (43.5)113 (36.7)69 (62.7)
Do you follow a resuscitation strategy aiming at normalizing capillary refill time, n (%)
 Never218 (52.2)184 (59.7)34 (30.9)< 0.001
 Sometimes175 (41.9)116 (37.7)59 (53.6)
 Always25 (6.0)8 (2.6)17 (15.5)
Is there a capillary refill time goal directed therapy-based protocol in your institution, n (%)
 No375 (89.7)282 (91.6)93 (84.5)0.093
 Yes13 (3.1)7 (2.3)6 (5.5)
 I don’t know30 (7.2)19 (6.2)11 (10.0)
Do you report capillary refill time in the medical record (%)
 Never113 (27.0)109 (35.4)4 (3.6)< 0.001
 Sometimes226 (54.1)174 (56.5)52 (47.3)
 Always79 (18.9)25 (8.1)54 (49.1)
Do you personally perform capillary refill time?
 Yes342 (81.8)233 (75.6)109 (99.1)< 0.001
Fig. 1

Main considerations regarding CRT according to the 418 survey respondents. CRT: Capillary refill time

How respondents use and interpret capillary refill time Main considerations regarding CRT according to the 418 survey respondents. CRT: Capillary refill time

How CRT is performed in clinical practice

When performing CRT in patients with acute circulatory failure, 42% of respondents declared assessing CRT 3 to 6 times per day and 50% reported doing it 1 to 2 times per day. CRT is measured at the thorax level for 58% of respondents, at the finger level for 51%, and at the knee level for 40%. To control the pressure applied to the skin, 25% use a specific technique and 75% just apply a firm pressure. The skin is compressed during less than 4 seconds according to 60% of respondents, and 98% assess the compression duration without a chronometer. Forty-six percent averaged at least two consecutive CRT measurements (Table 3).
Table 3

Technical details on how CRT is performed in clinical practice

OverallAdult practicePediatric practicep-value
n = 418n = 308n = 110
If you think of the last patient with acute circulatory failure, how often did you assess capillary refill time, n (%)
 0 /24 h26 (6.2)25 (8.1)1 (0.9)< 0.001
 1 to 2 /24 h165 (39.5)141 (45.8)24 (21.8)
 3 to 6/24 h137 (32.8)56 (18.2)81 (73.6)
 No answer90 (21.5)86 (27.9)4 (3.6)
On what part of the body do you assess capillary refill time, n (%)
 On the fingertip (%)169 (40.4)138 (44.8)31 (28.2)< 0.001
 On the thorax (%)191 (45.7)86 (27.9)105 (95.5)
 On the knee (%)131 (31.3)107 (34.7)24 (21.8)
 On the gingiva (%)5 (1.2)4 (1.3)1 (0.9)
How do you control the pressure during the compression of the skin, n (%)
 You apply a firm pressure247 (59.1)164 (53.2)83 (75.5)< 0.001
 You use the blanching of your finger nail to assess the pressure74 (17.7)51 (16.6)23 (20.9)
 You use a glass microscope slide to assess the blanching of the patient’s skin7 (1.7)7 (2.3)0 (0.0)
 No answer90 (21.5)86 (27.9)4 (3.6)
How long does the compression last, n (%)
 0 to 3 seconds192 (45.9)145 (47.1)47 (42.7)< 0.001
 4 to 7 seconds119 (28.5)62 (20.1)57 (51.8)
 7 to 10 seconds12 (2.9)10 (3.2)2 (1.8)
 >  10 seconds5 (1.2)5 (1.6)0 (0.0)
 No answer90 (21.5)86 (27.9)4 (3.6)
How do you measure the duration of the compression, n (%)
 Using a chronometer8 (1.9)8 (2.6)0 (0.0)< 0.001
 Counting in your head320 (76.6)214 (69.5)106 (96.4)
 No answer90 (21.5)86 (27.9)4 (3.6)
How do you measure capillary refill time, n (%)
 Using a chronometer12 (2.9)12 (3.9)0 (0.0)< 0.001
 Counting in your head316 (75.6)210 (68.2)106 (96.4)
 No answer90 (21.5)86 (27.9)4 (3.6)
To evaluate the capillary refill time of a patient at a given moment, how many CRT do you average, n (%)
 1 measurement102 (24.4)81 (26.3)21 (19.1)< 0.001
 2 measurement147 (35.2)99 (32.1)48 (43.6)
 3 measurement47 (11.2)28 (9.1)19 (17.3)
 the longest of the measurements performed32 (7.7)14 (4.5)18 (16.4)
 No answer90 (21.5)86 (27.9)4 (3.6)
Technical details on how CRT is performed in clinical practice

Leads to improve clinical practice

Among the obstacles that limit the widespread use of CRT during routine practice, 51% of respondents pointed out the difficulty in obtaining a reliable measurement, and 42 and 57% reported the lack of medical staff and non-medical staff training, respectively (Table 4). A large majority (90%) considered that CRT measurements could be performed by the non-medical staff. The main leads for improving the daily clinical use of CRT were to delegate measurements to a specifically trained non-medical staff (64%) and to use a dedicated device (54%). In the last open question, which aimed to collect further comments, respondents insisted on the fact that CRT could not be taken as a standalone variable, but should rather be integrated in a multivariable approach (Fig. 2).
Table 4

Leads to improve capillary refill time in clinical practice

What are according to you the obstacles for a more widespread use of capillary refill time, n (%)
 The lack of clinical benefit78 (18.7)67 (21.8)11 (10.0)0.004
 The difficulty to obtain a reliable measurement197 (47.1)146 (47.4)51 (46.4)
 The fact that obtaining a reliable measurement is time consuming18 (4.3)16 (5.2)2 (1.8)
 The lack of training of non-medical staff220 (52.6)154 (50.0)66 (60.0)
 The lack of training of medical staff161 (38.5)134 (43.5)27 (24.5)
According to you, can non-medical staff, following a dedicated training, handle the measurement of capillary refill time, n (%).
 No9 2.2)8 (2.6)1 (0.9)0.148
 Yes375 (89.7)271 (88.0)104 (94.5)
 No answer34 (8.1)29 (9.4)5 (4.5)
What could, according to you, improve the reliability of capillary refill time in clinical practice, n (%)e
 We should abandon this useless measurement20 (4.8)20 (6.5)0 (0.0)0.011
 CRT should be performed by a trained medical staff116 (27.8)89 (28.9)27 (24.5)
 CRT should be performed by a trained non-medical staff245 (58.6)165 (53.6)80 (72.7)
 CRT should be performed by non-medical staff without specific training21 (5.0)17 (5.5)4 (3.6)
 A specific device that measures CRT should be used208 (49.8)155 (50.3)53 (48.2)
Fig. 2

Word cloud obtained from the responses to the open question “Do you have a comment to make about CRT?”

Leads to improve capillary refill time in clinical practice Word cloud obtained from the responses to the open question “Do you have a comment to make about CRT?”

Differences between adult and pediatric physicians

In routine clinical practice, CRT is used more often by pediatric intensivists (99%) compared to adult ones (76%). The former more frequently reported that CRT is a reliable and reproducible measure and were more confident in the diagnostic value of CRT in the setting of acute circulatory failure. They also more strongly believed in the effectiveness of CRT-based perfusion goal-directed therapy, 63% of them being convinced that CRT is useful at the bedside compared to 37% of adult intensivists. In terms of the technical approach used for CRT measurement, pediatric intensivists used longer compression times and more often averaged multiple measurements (Tables 2 and 3).

Discussion

This survey found that the majority of physicians use CRT, more likely for its diagnostic than its prognostic value. Less than half of them think that a CRT-based perfusion goal-directed therapy can reduce mortality during acute circulatory failure. The standardized approach used in clinical studies does not seem to be applied during routine practice, as almost none of the respondents reported using a chronometer to measure CRT. Pediatric intensivists were more trustful of CRT in terms of reliability, reproducibility, and diagnostic ability, and their approach was closer to the required standards when compared to adult intensivists. CRT has been correlated to microcirculatory and perfusion variables such as NIRS [8], video microscopy, and lactate, and has been shown to be a strong prognostic factor in different settings [9-11], including acute circulatory failure [1]. Moreover, CRT has the advantage of being faster, cheaper, and easier to use than specific devices assessing microcirculation and has been used as a triage method [12]. Furthermore, clinical trials suggest a benefit of a CRT-targeted treatment strategy in acute circulatory failure [4, 13, 14] or during the deresuscitation phase [15, 16]. However, the results of the trial by Hernandez et al. [4]were strongly debated and led to ancillary Bayesian analyses [5] which confirmed the potential benefit of such strategies targeting CRT [17]. Ongoing studies may confirm the encouraging results in coming years [18, 19]. Although most of the respondents herein recognized the clinical usefulness of CRT they did not trust its prognostic value and most of them were not convinced that CRT-based perfusion-goal directed therapy could improve the outcome of patients with acute circulatory failure. In the pediatric setting, although the prognostic value of CRT is clear [20] there is less data from interventional studies concerning CRT-targeted therapy than in the adult setting. Nevertheless, the pediatric respondents of the present survey were more confident in the ability to improve outcome if CRT-targeted therapy is applied. This could be due to the fact that CRT-related literature is less recent and more abundant in the pediatric than the adult setting. Moreover, in textbooks considering perfusion assessment in children, CRT is described as one of the signs of circulatory failure and pediatric septic shock [21] . CRT is also used to define septic shock in pediatric randomized clinical trial [22]. This could also be explained by the fact that the pediatric approach is more focalized on noninvasive assessments of circulation as well as the higher need to spare blood in children. For instance, recent guidelines recommend titrating fluid load based on clinical surrogates of cardiac output, which include CRT [23]. In the Hernandez et al. clinical trial, CRT was measured by applying firm pressure to the ventral surface of distal phalanx of the right index finger with a glass microscope slide. Compression time was 10 seconds and the time for normal skin color to return was registered using a chronometer [4]. In the study by Ait-oufella et al. [1], the compression time was 15 seconds and the pressure applied “was just enough to remove the blood at the tip of the physician’s nail illustrated by appearance of a thin white distal crescent (blanching) under the nail”. A chronometer was also used and two measurements were averaged [1]. Others have shown that a syringe filled with air can also be used as a piston to control the pressure applied [24, 25]. Although the absence of link between cardiac output and CRT has been shown [26], its link to tissue perfusion is more obvious [12, 27] and consistent with the loss of hemodynamic coherence in septic shock and acute circulatory failure [28, 29]. Respondents appeared in accordance with these data as they trusted more CRT as a perfusion surrogate than a cardiac output surrogate marker. The present study has some limitations. With only a 7% response rate, one could argue the results are not representative of the French intensivist population. This rate is however comparable to other studies using the SFAR [30, 31]or the GFRUP networks [32]. Nevertheless, it cannot be excluded that the physicians who decided not to participate were more likely to not use CRT regularly resulting in a possible overestimation of CRT use. This could be due to the networks used to dispatch the survey, as among the anesthesiologist and intensivist members of the SFAR network, only a minority work in ICUs, although the latter are the most likely to manage patients with acute circulatory failure. Given that in France there are 775 anesthesiologists and intensivists working in adult ICUs and 214 of these answered the survey, this represents a 28% response rate from those most likely to manage acute circulatory failure. As the survey was written in French language, this likely impedes the generalizability of the results, as does the fact that a majority of respondents worked in public hospitals. Finally, a selection bias was presumably present, as intensivists with a special interest in CRT were more likely to respond. Nevertheless, in the absence of a previous evaluation of CRT use in routine practice, these results provide a relevant picture of current practices in France.

Conclusion

CRT is widely used by physicians managing acute circulatory failure, but most often in a sub-optimal way. Moreover, a gap remains between available data and the degree of confidence in CRT to predict patient outcome or to help clinical decision-making and resuscitation strategies. This may lead to a misunderstanding of the reliability and clinical usefulness of CRT. A simple way to increase the reliability of CRT would be the use of a chronometer, reducing the variation in compression level, and averaging several measurements. Nurse training programs and/or the use of specific devices should help standardize CRT measurements and render CRT-targeted therapy effective in routine clinical practice. Additional file 1. Survey letter. Additional file 2. Questionnaire.
  28 in total

1.  Microvascular blood flow is altered in patients with sepsis.

Authors:  Daniel De Backer; Jacques Creteur; Jean-Charles Preiser; Marc-Jacques Dubois; Jean-Louis Vincent
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

Review 2.  The holistic view on perfusion monitoring in septic shock.

Authors:  Glenn Hernandez; Alejandro Bruhn; Ricardo Castro; Tomas Regueira
Journal:  Curr Opin Crit Care       Date:  2012-06       Impact factor: 3.687

3.  Early peripheral perfusion-guided fluid therapy in patients with septic shock.

Authors:  Michel E van Genderen; Noel Engels; Ralf J P van der Valk; Alexandre Lima; Eva Klijn; Jan Bakker; Jasper van Bommel
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

4.  Persistent peripheral and microcirculatory perfusion alterations after out-of-hospital cardiac arrest are associated with poor survival.

Authors:  Michel E van Genderen; Alexandre Lima; Martijn Akkerhuis; Jan Bakker; Jasper van Bommel
Journal:  Crit Care Med       Date:  2012-08       Impact factor: 7.598

5.  Effects of a Resuscitation Strategy Targeting Peripheral Perfusion Status versus Serum Lactate Levels among Patients with Septic Shock. A Bayesian Reanalysis of the ANDROMEDA-SHOCK Trial.

Authors:  Fernando G Zampieri; Lucas P Damiani; Jan Bakker; Gustavo A Ospina-Tascón; Ricardo Castro; Alexandre B Cavalcanti; Glenn Hernandez
Journal:  Am J Respir Crit Care Med       Date:  2020-02-15       Impact factor: 21.405

6.  Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial.

Authors:  Glenn Hernández; Gustavo A Ospina-Tascón; Lucas Petri Damiani; Elisa Estenssoro; Arnaldo Dubin; Javier Hurtado; Gilberto Friedman; Ricardo Castro; Leyla Alegría; Jean-Louis Teboul; Maurizio Cecconi; Giorgio Ferri; Manuel Jibaja; Ronald Pairumani; Paula Fernández; Diego Barahona; Vladimir Granda-Luna; Alexandre Biasi Cavalcanti; Jan Bakker; Glenn Hernández; Gustavo Ospina-Tascón; Lucas Petri Damiani; Elisa Estenssoro; Arnaldo Dubin; Javier Hurtado; Gilberto Friedman; Ricardo Castro; Leyla Alegría; Jean-Louis Teboul; Maurizio Cecconi; Maurizio Cecconi; Giorgio Ferri; Manuel Jibaja; Ronald Pairumani; Paula Fernández; Diego Barahona; Alexandre Biasi Cavalcanti; Jan Bakker; Glenn Hernández; Leyla Alegría; Giorgio Ferri; Nicolás Rodriguez; Patricia Holger; Natalia Soto; Mario Pozo; Jan Bakker; Deborah Cook; Jean-Louis Vincent; Andrew Rhodes; Bryan P Kavanagh; Phil Dellinger; Wim Rietdijk; David Carpio; Nicolás Pavéz; Elizabeth Henriquez; Sebastian Bravo; Emilio Daniel Valenzuela; Magdalena Vera; Jorge Dreyse; Vanessa Oviedo; Maria Alicia Cid; Macarena Larroulet; Edward Petruska; Claudio Sarabia; David Gallardo; Juan Eduardo Sanchez; Hugo González; José Miguel Arancibia; Alex Muñoz; Germán Ramirez; Florencia Aravena; Andrés Aquevedo; Fabián Zambrano; Milan Bozinovic; Felipe Valle; Manuel Ramirez; Victor Rossel; Pilar Muñoz; Carolina Ceballos; Christian Esveile; Cristian Carmona; Eva Candia; Daniela Mendoza; Aída Sanchez; Daniela Ponce; Daniela Ponce; Jaime Lastra; Bárbara Nahuelpán; Fabrizio Fasce; Cecilia Luengo; Nicolas Medel; Cesar Cortés; Luz Campassi; Paolo Rubatto; Nahime Horna; Mariano Furche; Juan Carlos Pendino; Lisandro Bettini; Carlos Lovesio; María Cecilia González; Jésica Rodruguez; Héctor Canales; Francisco Caminos; Cayetano Galletti; Estefanía Minoldo; Maria Jose Aramburu; Daniela Olmos; Nicolás Nin; Jordán Tenzi; Carlos Quiroga; Pablo Lacuesta; Agustín Gaudín; Richard Pais; Ana Silvestre; Germán Olivera; Gloria Rieppi; Dolores Berrutti; Marcelo Ochoa; Paul Cobos; Fernando Vintimilla; Vanessa Ramirez; Milton Tobar; Fernanda García; Fabricio Picoita; Nelson Remache; Vladimir Granda; Fernando Paredes; Eduardo Barzallo; Paul Garcés; Fausto Guerrero; Santiago Salazar; German Torres; Cristian Tana; José Calahorrano; Freddy Solis; Pedro Torres; Luís Herrera; Antonio Ornes; Verónica Peréz; Glenda Delgado; Alexei López; Eliana Espinosa; José Moreira; Blanca Salcedo; Ivonne Villacres; Jhonny Suing; Marco Lopez; Luis Gomez; Guillermo Toctaquiza; Mario Cadena Zapata; Milton Alonso Orazabal; Ruben Pardo Espejo; Jorge Jimenez; Alexander Calderón; Gustavo Paredes; José Luis Barberán; Tatiana Moya; Horacio Atehortua; Rodolfo Sabogal; Guillermo Ortiz; Antonio Lara; Fabio Sanchez; Alvaro Hernán Portilla; Humberto Dávila; Jorge Antonio Mora; Luis Eduardo Calderón; Ingrid Alvarez; Elena Escobar; Alejandro Bejarano; Luis Alfonso Bustamante; José Luis Aldana
Journal:  JAMA       Date:  2019-02-19       Impact factor: 56.272

7.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

Authors:  Laura Evans; Andrew Rhodes; Waleed Alhazzani; Massimo Antonelli; Craig M Coopersmith; Craig French; Flávia R Machado; Lauralyn Mcintyre; Marlies Ostermann; Hallie C Prescott; Christa Schorr; Steven Simpson; W Joost Wiersinga; Fayez Alshamsi; Derek C Angus; Yaseen Arabi; Luciano Azevedo; Richard Beale; Gregory Beilman; Emilie Belley-Cote; Lisa Burry; Maurizio Cecconi; John Centofanti; Angel Coz Yataco; Jan De Waele; R Phillip Dellinger; Kent Doi; Bin Du; Elisa Estenssoro; Ricard Ferrer; Charles Gomersall; Carol Hodgson; Morten Hylander Møller; Theodore Iwashyna; Shevin Jacob; Ruth Kleinpell; Michael Klompas; Younsuck Koh; Anand Kumar; Arthur Kwizera; Suzana Lobo; Henry Masur; Steven McGloughlin; Sangeeta Mehta; Yatin Mehta; Mervyn Mer; Mark Nunnally; Simon Oczkowski; Tiffany Osborn; Elizabeth Papathanassoglou; Anders Perner; Michael Puskarich; Jason Roberts; William Schweickert; Maureen Seckel; Jonathan Sevransky; Charles L Sprung; Tobias Welte; Janice Zimmerman; Mitchell Levy
Journal:  Intensive Care Med       Date:  2021-10-02       Impact factor: 17.440

Review 8.  The Diagnostic Value of Capillary Refill Time for Detecting Serious Illness in Children: A Systematic Review and Meta-Analysis.

Authors:  Susannah Fleming; Peter Gill; Caroline Jones; James A Taylor; Ann Van den Bruel; Carl Heneghan; Nia Roberts; Matthew Thompson
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

9.  Targeted tissue perfusion versus macrocirculation-guided standard care in patients with septic shock (TARTARE-2S): study protocol and statistical analysis plan for a randomized controlled trial.

Authors:  Ville Pettilä; Tobias Merz; Erika Wilkman; Anders Perner; Sari Karlsson; Theis Lange; Johanna Hästbacka; Peter Buhl Hjortrup; Anne Kuitunen; Stephan M Jakob; Jukka Takala
Journal:  Trials       Date:  2016-08-02       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.